microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis

Sankhiros Babapoor, Michael Horwich, Rong Wu, Shauna Levinson, Manoj Gandhi, Hanspaul Makkar, Arni Kristjansson, Mary Chang, Soheil S. Dadras*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

Some melanocytic tumors can be histologically ambiguous causing diagnostic difficulty, which could lead to overtreatment of benign lesions with an unwarranted psychological distress or undertreatment of malignant cancers. Previously, we demonstrated that significantly decreased miR-211 expression in melanomas compared with melanocytic nevi could accurately discriminate malignant from benign tumors. Herein we show microRNA in situ hybridization for fluorescent detection of miR-211, suitable for paraffin-embedded tissues in 109 primary melanocytic tumors. miR-211 expression was significantly lower in melanomas vs nevi (P<0.0001), and receiver operating characteristic curve (area under the curve=0.862) accurately discriminated melanomas from nevi with 90% sensitivity and 86.2% specificity. Qualitatively, all dysplastic nevi expressed miR-211 at high (86%) and low (14%) levels, independent of the degree of nuclear atypia. All 35 melanocytic tumors with Spitz morphology expressed miR-211 independent of morphological classification, where clinical follow-up of these patients showed no recurrence at the site or metastasis in mean and median of 3 (ranging 2-5) years. Moreover, a decision tree learning analysis selected age and miR-211 miRNA in situ hybridization as the predictive variables for benign or malignant outcome in 88 patients correctly classified 92% (81 out of 88) of cases as proven by receiver operating characteristic curve (area under the curve=0.9029). These results support miR-211 as a leading miRNA candidate for melanoma diagnosis and miRNA in situ hybridization as a uniquely uncomplicated ancillary test.

Original languageEnglish
Pages (from-to)461-475
Number of pages15
JournalModern Pathology
Volume29
Issue number5
DOIs
Publication statusPublished - 1 May 2016

Bibliographical note

Publisher Copyright:
© 2016 USCAP, Inc All rights reserved.

Fingerprint

Dive into the research topics of 'microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis'. Together they form a unique fingerprint.

Cite this